Judy Henry: From Herbalist to Entrepreneur

Sep.08.2022
Judy Henry: From Herbalist to Entrepreneur
Judy Henry, Idaho entrepreneur, developed all-natural formulas mimicking addictive nicotine and SARMS, but is unable to sell due to FDA regulations.

Judy Henry, an entrepreneur from Idaho, USA, has had a lifelong passion for plants and herbs. She spent several years researching the benefits of herbal medicine for health and has developed it into a lifelong career.


I use plant-based products because I grew up with them and understand what they can do for our bodies," Henry said during the interview.


I truly believe that God has placed everything we need on this earth," she continued. "They are the culmination of knowledge from previous generations who embraced plant medicine because of the powerful impact it has on our overall well-being.


This belief guides the life of Judy Henry. Furthermore, this belief has developed into something unique for her. Sacred Body Botanicals is the result of her dedication. Her accomplishment is building a small, natural health and wellness brand, which ultimately grew into a laboratory for innovative products developed over the years.


As a former smoker, Henry saw an opportunity to improve health. Utilizing her expertise in herbal medicine, she created a series of all-natural formulas to mimic the pleasure of addictive nicotine. Henry patented several of these formulas, stating that they have attracted a broad customer base who have seen benefits in a short period of time.


One of the products is a nicotine-free e-liquid, which Henry claims is a nicotine detoxifier that can help people quit smoking.


She developed the NoNic product, which has had a promising start. She also launched a pilot program in the local community to offer workshops introducing customers to her NoNic product.


She said she has had success introducing her NoNic formula to clients struggling with nicotine addiction in a few short meetings. Henry pointed out that due to FDA regulations, the product has not undergone medical review and she cannot promote its health benefits. However, she said some of her clients have provided positive feedback. One story she shared with me was particularly notable. A gentleman started using the NoNic formula and claimed he immediately became addicted to it, never smoking again. She has seen real-life success with NoNic.


However, the harsh reality is that selling plant-based formulations in the United States is illegal without invasive and expensive FDA inspections and approvals or other bans on products not federally approved. Despite creating a product that is almost entirely different from others on the market, the law forbids Henry from selling NoNic through her company, Sacred Body Botanicals.


In 2020, the United States Congress passed the controversial Preventing Online Sales of E-Cigarettes to Children Act, which amended the Prevent All Cigarette Trafficking (PACT) Act of 2009. The new law allows the Federal Alcohol, Tobacco, and Firearms (ATF) agency to actively enforce rules governing the interstate sale of tobacco products. The Preventing Online Sales of E-Cigarettes to Children Act expands upon the existing PACT Act by including a broad definition that encompasses e-cigarette devices and includes a ban on e-cigarette mailings enforced by the United States Postal Service.


Disclaimer: 1. This article is compiled from third-party information, and is only provided for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article content. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of compilation skills, the compiled article may not express the same meaning as the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macau, Taiwan, or foreign statements and positions, 2FIRSTS fully aligns with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
PMI’s ZYN Launches Loyalty Platform in Mexico, Tapping World Cup Viewing Scenes for Nicotine Pouch Marketing
PMI’s ZYN Launches Loyalty Platform in Mexico, Tapping World Cup Viewing Scenes for Nicotine Pouch Marketing
PMI’s nicotine pouch brand ZYN has launched the ZYN Club loyalty platform in Mexico and introduced ZYN Live Stadium viewing experiences around football matches, showing how nicotine pouch brands are using rewards, limited benefits and offline consumption settings to reach adult consumers.
Jun.29
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
China Tobacco International HK Warns First-Half Revenue May Fall 25%-30%, Tobacco Leaf and Duty-Free Exposure Highlight Reliance on Traditional Tobacco
CTIHK expects first-half 2026 revenue to fall 25%-30%, mainly due to lower tobacco leaf imports and delayed cigarette shipments to China’s domestic duty-free market. Its 2025 revenue mix—nearly 90% from tobacco leaf-related businesses and less than 1% from new tobacco products—shows continued exposure to traditional supply chains and trade variables.
Jun.18
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France remains one of Europe’s active vape markets in 2026, with adult vaping prevalence rising to 7.9%; at the same time, e-liquid taxation, public-space restrictions, advertising compliance and health-risk debate are pushing the industry into a critical policy period.
Jun.23
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysian police plan to use saliva test kits at roadblocks to detect drivers using synthetic liquid drugs marketed as “Piu Piu” and “Magic Mushroom,” substances that authorities say are mixed into vape liquids and inhaled through e-cigarette devices, raising road-safety concerns and adding pressure on vape regulation.
Jun.29